Matinas BioPharma Files 8-K on Equity Sales
Ticker: MTNB · Form: 8-K · Filed: Apr 8, 2025 · CIK: 1582554
| Field | Detail |
|---|---|
| Company | Matinas Biopharma Holdings, Inc. (MTNB) |
| Form Type | 8-K |
| Filed Date | Apr 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-sale, filing
Related Tickers: MTNB
TL;DR
Matinas BioPharma filed an 8-K for unregistered equity sales. Keep an eye on dilution.
AI Summary
Matinas BioPharma Holdings, Inc. filed an 8-K on April 8, 2025, reporting on unregistered sales of equity securities and other events. The filing details the company's corporate information, including its address in Bedminster, New Jersey, and its fiscal year end of December 31.
Why It Matters
This filing indicates potential equity transactions by Matinas BioPharma, which could impact its capital structure and shareholder equity.
Risk Assessment
Risk Level: medium — Unregistered sales of equity securities can sometimes signal a need for capital or potential dilution for existing shareholders.
Key Players & Entities
- Matinas BioPharma Holdings, Inc. (company) — Registrant
- April 8, 2025 (date) — Date of Report
- Bedminster, New Jersey (location) — Principal Executive Offices
- 07921 (postal_code) — Zip Code
- 46-3011414 (tax_id) — IRS Employer ID Number
FAQ
What specific type of equity securities were sold unregistered?
The filing states 'Unregistered Sales of Equity Securities' as an item information, but does not specify the type of securities in the provided text.
When was the earliest event reported in this 8-K?
The earliest event reported is April 8, 2025, which is also the date of the report.
What is Matinas BioPharma's principal executive office address?
The principal executive offices are located at 1545 Route 206 South, Suite 302, Bedminster, New Jersey 07921.
What is the company's IRS Employer Identification Number?
The IRS Employer Identification Number is 46-3011414.
What is the company's Standard Industrial Classification code?
The Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2025 regarding Matinas BioPharma Holdings, Inc. (MTNB).